CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | SANTINI GINO Director | Option exercise | +8,700 | $16.49 | $143K | 112,483 |
| 2026-06-08 | SANTINI GINO Director | Option exercise · Stock Option (Right to Purchase) | −8,700 | 0 | ||
| 2026-05-18 | Freund John Gordon Director | Sale | −20 | $34.05 | $681 | 83,952 |
| 2026-05-15 | Freund John Gordon Director | Option exercise | +8,700 | $16.49 | $143K | 88,099 |
| 2026-05-15 | Freund John Gordon Director | Sale | −4,127 | $34.54 | $143K | 83,972 |
| 2026-05-15 | Freund John Gordon Director | Option exercise · Stock Option (Right to Purchase) | −8,700 | 0 | ||
| 2026-05-14 | Glancy Donovan Michael Director | Grant or award | +17,482 | 17,482 | ||
| 2026-05-14 | Balice-Gordon Rita J. Director | Grant or award | +8,741 | 61,370 | ||
| 2026-05-14 | Paya Carlos V Director | Grant or award | +8,741 | 28,323 | ||
| 2026-05-14 | Lurker Nancy Director | Grant or award | +8,741 | 26,758 | ||
| 2026-05-14 | Freund John Gordon Director | Grant or award | +8,741 | 79,399 | ||
| 2026-05-14 | SANTINI GINO Director | Grant or award | +8,741 | 103,783 | ||
| 2026-05-14 | BOHLIN GAREN G Director | Grant or award | +8,741 | 71,000 | ||
| 2026-05-13 | Lurker Nancy Director | Sale | −4,500 | $35.97 | $162K | 18,017 |
| 2026-05-11 | BOHLIN GAREN G Director | Option exercise | +8,700 | $16.49 | $143K | 70,959 |
| 2026-05-11 | BOHLIN GAREN G Director | Sale | −8,700 | $37.18 | $323K | 62,259 |
| 2026-05-11 | BOHLIN GAREN G Director | Option exercise · Stock Option (Right to Purchase) | −8,700 | 0 | ||
| 2026-03-18 | Dieter David EVP & General Counsel | Sale 10b5-1 | −13,976 | $34.92 | $488K | 77,071 |
| 2026-03-17 | Dieter David EVP & General Counsel | Shares withheld for taxes | −8,840 | $35.72 | $316K | 68,231 |
| 2026-03-09 | Dieter David EVP & General Counsel | Sale 10b5-1 | −6,224 | $36.65 | $228K | 91,047 |
Page 1 of 24 · 462 trades